Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Integrating a Disease-Specific Migraine App Into the Management of Patients in the Primary Care Setting

NCT03559088 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT03559088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03559088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Integrating a Disease-Specific Migraine App Into the Management of Patients in the Primary Care Setting
Lead sponsor
Eli Lilly and Company
Phase
Not applicable
Overall status
Completed
Start date
June 11, 2018
Completion date
April 26, 2019
Enrollment
120 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

migraine